Frontiers in Cellular Neuroscience,
Journal Year:
2017,
Volume and Issue:
11
Published: April 28, 2017
Gastrointestinal
(GI)
symptoms
are
a
common
comorbidity
in
patients
with
autism
spectrum
disorder
(ASD),
but
the
underlying
mechanisms
unknown.
Many
studies
have
shown
alterations
composition
of
fecal
flora
and
metabolic
products
gut
microbiome
ASD.
The
microbiota
influences
brain
development
behaviors
through
neuroendocrine,
neuroimmune
autonomic
nervous
systems.
In
addition,
an
abnormal
is
associated
several
diseases,
such
as
inflammatory
bowel
disease
(IBD),
ASD
mood
disorders.
Here,
we
review
bidirectional
interactions
between
central
system
gastrointestinal
tract
(brain-gut
axis)
role
Microbiome-mediated
therapies
might
be
safe
effective
treatment
for
Physiological Reviews,
Journal Year:
2019,
Volume and Issue:
99(4), P. 1877 - 2013
Published: Aug. 28, 2019
The
importance
of
the
gut-brain
axis
in
maintaining
homeostasis
has
long
been
appreciated.
However,
past
15
yr
have
seen
emergence
microbiota
(the
trillions
microorganisms
within
and
on
our
bodies)
as
one
key
regulators
function
led
to
appreciation
a
distinct
microbiota-gut-brain
axis.
This
is
gaining
ever
more
traction
fields
investigating
biological
physiological
basis
psychiatric,
neurodevelopmental,
age-related,
neurodegenerative
disorders.
brain
communicate
with
each
other
via
various
routes
including
immune
system,
tryptophan
metabolism,
vagus
nerve
enteric
nervous
involving
microbial
metabolites
such
short-chain
fatty
acids,
branched
chain
amino
peptidoglycans.
Many
factors
can
influence
composition
early
life,
infection,
mode
birth
delivery,
use
antibiotic
medications,
nature
nutritional
provision,
environmental
stressors,
host
genetics.
At
extreme
diversity
diminishes
aging.
Stress,
particular,
significantly
impact
at
all
stages
life.
Much
recent
work
implicated
gut
many
conditions
autism,
anxiety,
obesity,
schizophrenia,
Parkinson’s
disease,
Alzheimer’s
disease.
Animal
models
paramount
linking
regulation
fundamental
neural
processes,
neurogenesis
myelination,
microbiome
activation
microglia.
Moreover,
translational
human
studies
are
ongoing
will
greatly
enhance
field.
Future
focus
understanding
mechanisms
underlying
attempt
elucidate
microbial-based
intervention
therapeutic
strategies
for
neuropsychiatric
Microbiology and Molecular Biology Reviews,
Journal Year:
2017,
Volume and Issue:
81(4)
Published: Nov. 8, 2017
SUMMARY
The
human
gut
microbiota
is
engaged
in
multiple
interactions
affecting
host
health
during
the
host's
entire
life
span.
Microbes
colonize
neonatal
immediately
following
birth.
establishment
and
interactive
development
of
this
early
are
believed
to
be
(at
least
partially)
driven
modulated
by
specific
compounds
present
milk.
It
has
been
shown
that
certain
genomes
infant
commensals,
particular
those
bifidobacterial
species,
genetically
adapted
utilize
glycans
secretory
fluid,
thus
representing
a
very
intriguing
example
host-microbe
coevolution,
where
both
partners
benefit.
In
recent
years,
various
metagenomic
studies
have
tried
dissect
composition
functionality
microbiome
explore
distribution
across
different
ecological
niches
biogeography
corresponding
microbial
consortia,
including
bacteria
viruses,
healthy
ill
subjects.
Such
analyses
linked
features
microbiota/microbiome,
such
as
reduced
diversity
or
aberrant
composition,
intestinal
illnesses
infants
disease
states
manifested
at
later
stages
life,
asthma,
inflammatory
bowel
disease,
metabolic
disorders.
Thus,
growing
number
reported
on
how
composition/development
may
affect
risk
factors
related
adult
conditions.
This
concept
fueled
strategies
shape
based
functional
food
products.
review,
we
describe
microbiota,
mechanisms
drive
its
consortia
molded
natural
artificial
interventions.
Finally,
discuss
relevance
key
players
bifidobacteria,
with
respect
their
role
disease.
Nature,
Journal Year:
2018,
Volume and Issue:
562(7728), P. 583 - 588
Published: Oct. 1, 2018
The
development
of
the
microbiome
from
infancy
to
childhood
is
dependent
on
a
range
factors,
with
microbial–immune
crosstalk
during
this
time
thought
be
involved
in
pathobiology
later
life
diseases1–9
such
as
persistent
islet
autoimmunity
and
type
1
diabetes10–12.
However,
our
knowledge,
no
studies
have
performed
extensive
characterization
early
large,
multi-centre
population.
Here
we
analyse
longitudinal
stool
samples
903
children
between
3
46
months
age
by
16S
rRNA
gene
sequencing
(n
=
12,005)
metagenomic
10,867),
part
Environmental
Determinants
Diabetes
Young
(TEDDY)
study.
We
show
that
developing
gut
undergoes
three
distinct
phases
progression:
developmental
phase
(months
3–14),
transitional
15–30),
stable
31–46).
Receipt
breast
milk,
either
exclusive
or
partial,
was
most
significant
factor
associated
structure.
Breastfeeding
higher
levels
Bifidobacterium
species
(B.
breve
B.
bifidum),
cessation
milk
resulted
faster
maturation
microbiome,
marked
phylum
Firmicutes.
Birth
mode
also
significantly
phase,
driven
Bacteroides
(particularly
fragilis)
infants
delivered
vaginally.
increased
diversity
maturation,
regardless
birth
mode.
factors
including
geographical
location
household
exposures
(such
siblings
furry
pets)
represented
important
covariates.
A
nested
case–control
analysis
revealed
subtle
associations
microbial
taxonomy
diabetes.
These
data
determine
structural
functional
assembly
provide
foundation
for
targeted
mechanistic
investigation
into
consequences
long-term
health.
Metagenomic
TEDDY
study
shows
breastfeeding
structure,
microbiome.
Microbiome,
Journal Year:
2017,
Volume and Issue:
5(1)
Published: April 28, 2017
After
more
than
a
century
of
active
research,
the
notion
that
human
fetal
environment
is
sterile
and
neonate's
microbiome
acquired
during
after
birth
was
an
accepted
dogma.
However,
recent
studies
using
molecular
techniques
suggest
bacterial
communities
in
placenta,
amniotic
fluid,
meconium
from
healthy
pregnancies.
These
findings
have
led
many
scientists
to
challenge
"sterile
womb
paradigm"
propose
acquisition
instead
begins
utero,
idea
would
fundamentally
change
our
understanding
gut
microbiota
its
role
development.
In
this
review,
we
provide
critical
assessment
evidence
supporting
these
two
opposing
hypotheses,
specifically
as
it
relates
(i)
anatomical,
immunological,
physiological
characteristics
placenta
fetus;
(ii)
research
methods
currently
used
study
microbial
populations
intrauterine
environment;
(iii)
fecal
first
days
life;
(iv)
generation
axenic
animals
humans.
Based
on
analysis,
argue
support
"in
utero
colonization
hypothesis"
extremely
weak
founded
almost
entirely
approaches
with
insufficient
detection
limit
"low-biomass"
populations,
lacked
appropriate
controls
for
contamination,
failed
viability.
Most
importantly,
ability
reliably
derive
via
cesarean
sections
strongly
supports
sterility
mammals.
We
conclude
current
scientific
does
not
existence
microbiomes
within
milieu,
which
has
implications
development
clinical
practices
prevent
perturbations
establishment
future
priorities.
Science Translational Medicine,
Journal Year:
2016,
Volume and Issue:
8(343)
Published: June 15, 2016
The
gut
microbial
community
is
dynamic
during
the
first
3
years
of
life,
before
stabilizing
to
an
adult-like
state.
However,
little
known
about
impact
environmental
factors
on
developing
human
microbiome.
We
report
a
longitudinal
study
microbiome
based
DNA
sequence
analysis
monthly
stool
samples
and
clinical
information
from
39
children,
half
whom
received
multiple
courses
antibiotics
life.
Whereas
most
children
born
by
vaginal
delivery
was
dominated
Bacteroides
species,
four
cesarean
section
20%
vaginally
lacked
in
6
18
months
Longitudinal
sampling,
coupled
with
whole-genome
shotgun
sequencing,
allowed
detection
strain-level
variation
as
well
abundance
antibiotic
resistance
genes.
microbiota
antibiotic-treated
less
diverse
terms
both
bacterial
species
strains,
some
often
single
strains.
In
addition,
we
observed
short-term
composition
changes
between
consecutive
treated
antibiotics.
Antibiotic
genes
carried
chromosomes
showed
peak
after
treatment
followed
sharp
decline,
whereas
mobile
elements
persisted
longer
therapy
ended.
Our
results
highlight
value
high-density
sampling
studies
high-resolution
strain
profiling
for
studying
establishment
response
perturbation
infant
Immunology,
Journal Year:
2018,
Volume and Issue:
154(2), P. 204 - 219
Published: March 7, 2018
Neurodegenerative
diseases,
the
leading
cause
of
morbidity
and
disability,
are
gaining
increased
attention
as
they
impose
a
considerable
socioeconomic
impact,
due
in
part
to
ageing
community.
Neuronal
damage
is
pathological
hallmark
Alzheimer's
Parkinson's
amyotrophic
lateral
sclerosis,
Huntington's
disease,
spinocerebellar
ataxia
multiple
although
such
also
observed
following
neurotropic
viral
infections,
stroke,
genetic
white
matter
diseases
paraneoplastic
disorders.
Despite
different
aetiologies,
for
example,
mutations,
trauma
protein
aggregations,
neuronal
frequently
associated
with
chronic
activation
an
innate
immune
response
CNS.
The
growing
awareness
that
system
inextricably
involved
shaping
brain
during
development
well
mediating
damage,
but
regeneration
repair,
has
stimulated
therapeutic
approaches
modulate
neurodegenerative
diseases.
Here,
we
review
current
understanding
how
astrocytes
microglia,
neurons
oligodendrocytes,
shape
neuroimmune
development,
aberrant
responses
arise
or
environmental
triggers
may
predispose
CNS
We
discuss
known
interactions
between
peripheral
brain,
concepts
on
cells
enter
leave
A
better
disease
will
be
key
further
manipulating
these
effective
therapies
improve
quality
life,
reduce
impact
neuroinflammatory
degenerative
Gut,
Journal Year:
2022,
Volume and Issue:
71(9), P. 1724 - 1762
Published: Aug. 8, 2022
Helicobacter
pylori
Infection
is
formally
recognised
as
an
infectious
disease,
entity
that
now
included
in
the
International
Classification
of
Diseases
11th
Revision.
This
principle
leads
to
recommendation
all
infected
patients
should
receive
treatment.
In
context
wide
clinical
spectrum
associated
with
gastritis,
specific
issues
persist
and
require
regular
updates
for
optimised
management.
The
identification
distinct
scenarios,
proper
testing
adoption
effective
strategies
prevention
gastric
cancer
other
complications
are
addressed.
H.
treatment
challenged
by
continuously
rising
antibiotic
resistance
demands
susceptibility
consideration
novel
molecular
technologies
careful
selection
first
line
rescue
therapies.
role
therapies
their
impact
on
gut
microbiota
also
considered.
Progress
made
management
infection
covered
present
sixth
edition
Maastricht/Florence
2021
Consensus
Report,
key
aspects
related
were
re-evaluated
updated.
Forty-one
experts
from
29
countries
representing
a
global
community,
examined
new
data
five
working
groups:
(1)
indications/associations,
(2)
diagnosis,
(3)
treatment,
(4)
prevention/gastric
(5)
microbiota.
results
individual
groups
presented
final
consensus
voting
participants.
Recommendations
provided
basis
best
available
evidence
relevance
various
fields.